Cargando…
615. A Prospective Cohort Study to Evaluate Performance of MycoMEIA – Aspergillus: A New Urine Diagnostic for Aspergillosis
BACKGROUND: The MycoMEIA urine diagnostic was developed as an enzyme immunoassay, by Johns Hopkins (JH) and Pearl Diagnostics. In a retrospective study of 310 people, the assay was 90.5% (95% CI 70-99) sensitive and 89.2% (95% CI 82-94) specific. We report results of a prospective study performed at...
Autores principales: | Permpalung, Nitipong, Rajack, Shakila, Marr, Kieren, Datta, Kausik, MacLean-Blevins, Dorothy, Ostrander, Darin B, Baburina, Irina, Neitzey, Dana, Marques, Patricia X, Zhang, Sean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679208/ http://dx.doi.org/10.1093/ofid/ofad500.681 |
Ejemplares similares
-
Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis
por: Permpalung, Nitipong, et al.
Publicado: (2021) -
Coronavirus Disease 2019–Associated Pulmonary Aspergillosis: A Noninvasive Screening Model for Additional Diagnostics
por: Permpalung, Nitipong, et al.
Publicado: (2023) -
Aspergillus lentulus: An Under-recognized Cause of Antifungal Drug-Resistant Aspergillosis
por: Nematollahi, Saman, et al.
Publicado: (2021) -
Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
por: Hawes, Armani M., et al.
Publicado: (2022) -
Aspergillosis Complicating Severe Coronavirus Disease
por: Marr, Kieren A., et al.
Publicado: (2021)